Bms.com - SEO Checker

Overview of the SEO Check
Meta information
86% 
Page quality
85% 
Page structure
58% 
Link structure
63% 
Server
83% 
External factors
100% 
SEO Score
Response time
0.75 s
File size
128.40 kB
Words
788
Media files
16
Number of links
164 internal / 22 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Global Biopharmaceutical Company - Bristol Myers Squibb
The length of the page title is perfect. (524 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
The meta description is too long: 1036 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.bms.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width,initial-scale=1
descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
google-site-verificationMOA_zkwraH_JsReOcsUwqULQpxy_bHgguqaLGpEjiAQ
langen-us
twitter:cardsummary
twitter:sitewww.bms.com
twitter:urlhttps://www.bms.com/
twitter:titleGlobal Biopharmaceutical Company - Bristol Myers Squibb
twitter:descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
twitter:imagehttps://www.bms.com/assets/bms/us/en-us/images/bristol-myers-squibb-new-logo.png
twitter:image:altFollow us on X
og:titleGlobal Biopharmaceutical Company - Bristol Myers Squibb
og:typewebsite
og:urlhttps://www.bms.com/
og:imagehttps://www.bms.com/assets/bms/us/en-us/images/bristol-myers-squibb-new-logo.png
og:descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
X-UA-CompatibleIE=edge,chrome=1
charsetUTF-8

Automatically check bms.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 788 words. That's ok.
22.5% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
6 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 13.3 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width,initial-scale=1" is provided.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 16 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
This page is optimized perfectly for social networks.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
.../bms/us/en-us/logos/bms-rebrand-logo.svgBristol Myers Squibbnull
...-us/images/scientific-hero-1920x1080.jpgDigital image of computer numbers and colorsDigital image of computer numbers and colors
...images/Christophe_cropHero-1920x1080.jpgAle & Christophe walking the dogAle & Christophe walking the dog
...woman-scientist-with-sample-to-light.jpgWoman scientist with sample to lightWoman scientist with sample to light
.../us/en-us/images/q1-earnings-642x856.jpgClose up of sample with beaker with various colorsClose up of sample with beaker with various colors
...-boerner-r-d-video-thumbnail1395x786.jpgChris Boerner standing outside a scientific labChris Boerner standing outside a scientific lab
.../images/Women-in-AI_HeroImage-mobile.jpgFemale scientist working at dual computer screens with imageryFemale scientist working at dual computer screens with imagery
...s/images/patient-in-office-home-tile.jpgpatient in doctor office with caring hand on shoulderpatient in doctor office with caring hand on shoulder
...es/Mobile-Annual-Report-2024-800x800.jpgillustrative cover of annual report with BMS branded colorsillustrative cover of annual report with BMS branded colors
.../gettyImages-science-480810981-story.jpgNew FDA approval for the most common type of liver cancer New FDA approval for the most common type of liver cancer
.../building-better-future-esg-1395x786.jpgmosaic cover of esg reportmosaic cover of esg report
/assets/bms/us/en-us/icons/Facebook.svgFacebookFacebook
/assets/bms/us/en-us/icons/Instagram.svgInstagramInstagram
/assets/bms/us/en-us/icons/Twitter.svgXX
/assets/bms/us/en-us/icons/Linkedin.svgLinkedInLinkedIn
/assets/bms/us/en-us/icons/YouTube.svgYouTubeYouTube

Page structure

H1 heading
(Critically important)
Global Biopharmaceutical Company - Bristol Myers Squibb
The H1 heading is perfect.
Headings
(Important)
Some headings occur twice on the page.
There are 82 headings on the page. The amount of headings should be in a more proper relation to the amount of text.
Some headings do not have any content.

Heading structure

Heading levelContent
H1 Global Biopharmaceutical Company - Bristol Myers Squibb
H2 Americas
H2 Asia Pacific
H2 Europe
H2 Middle East
H2 Other
H2 Patients & caregivers
H2 Healthcare providers
H2 Researchers
H2 Investors
H2 Business development
H2 News & media
H2 About us
H2 Empty heading
H2 Empty heading
H2 Empty heading
H2 Explore BMS
H2 Defining what’s possible​
H2 Looking for answers?
H2 Main navigation
H2 Resources
H2 Empty heading
H2 Empty heading
H2 Follow us
H3 Argentina
H3 Brazil
H3 Canada
H3 Chile
H3 Colombia
H3 Mexico
H3 Peru
H3 United States
H3 Australia
H3 China
H3 India
H3 Japan
H3 Korea
H3 New Zealand
H3 Singapore
H3 Taiwan
H3 Thailand
H3 Austria
H3 Belgium
H3 Czech Republic
H3 Denmark
H3 Finland
H3 France
H3 Germany
H3 Greece
H3 Hungary
H3 Ireland
H3 Italy
H3 Luxembourg
H3 Netherlands
H3 Norway
H3 Poland
H3 Portugal
H3 Romania
H3 Spain
H3 Sweden
H3 Switzerland
H3 United Kingdom
H3 Israel
H3 Saudi Arabia
H3 Turkey
H3 United Arab Emirates
H3 Other Markets
H3 Related links
H3 Related links Duplicate text
H3 Related links Duplicate text
H3 Related links Duplicate text
H3 Related links Duplicate text
H3 Related links Duplicate text
H3 Related links Duplicate text
H3 Building a Better Future Report
H4 2025 first quarter financial results
H4 Pursuing bold solutions through neuroscience research
H4 Women innovators in AI transforming patient care
H4 Scientific media resources
H4 New FDA approval for the most common type of liver cancer
H4 2024
H4 Science, Patients, Progress
H5 Read more, including important cautionary statements about forward-looking information.
H5 New FDA approval
H5 2024 Annual Report
H5 Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the development of new medicines with differentiated research platforms and a m...
H5 Our dual immunotherapy treatment option is now approved for the first-line treatment of certain patients with hepatocellular carcinoma.
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 22 external links on this page.
LinkAttributesAnchor text
/patient-and-caregivers/our-me...Our medicines
/about-us/our-science.htmlOur science
/life-and-science.htmlOur stories
https://www.bms.com/IMG-ALT Bristol Myers Squibb
https://www.bms.com/Anchor Skip to main content
/about-us/contact-us.htmlContact us
https://careers.bms.com/External Subdomain Careers
https://www.bms.com/United States
https://www.bms.com/arSpanish
https://www.bms.com/brPortuguese
https://www.bms.com/ca/enEnglish
https://www.bms.com/ca/frFrench
https://www.bms.com/clText duplicate Spanish
https://www.bms.com/coText duplicate Spanish
https://www.bms.com/mxText duplicate Spanish
https://www.bms.com/peText duplicate Spanish
https://www.bms.com/Text duplicate English
https://www.bms.com/auText duplicate English
https://www.bms.com/cnSimplified Chinese
https://www.bms.com/inText duplicate English
https://www.bms.com/jpJapanese
https://www.bms.com/krKorean
https://www.bms.com/nzText duplicate English
https://www.bms.com/sgText duplicate English
https://www.bms.com/twTraditional Chinese
https://www.bms.com/th/enText duplicate English
https://www.bms.com/th/thThai
https://www.bms.com/atGerman
https://www.bms.com/beText duplicate English
https://www.bms.com/be/nlDutch
https://www.bms.com/be/frText duplicate French
https://www.bms.com/czCzech
https://www.bms.com/dkDanish
https://www.bms.com/fiFinnish
https://www.bms.com/frText duplicate French
https://www.bms.com/deText duplicate German
https://www.bms.com/grGreek
https://www.bms.com/huHungarian
https://www.bms.com/ieText duplicate English
https://www.bms.com/itItalian
https://www.bms.com/luText duplicate English
https://www.bms.com/nl/enText duplicate English
https://www.bms.com/nlText duplicate Dutch
https://www.bms.com/noNorwegian
https://www.bms.com/plPolish
https://www.bms.com/ptText duplicate Portuguese
https://www.bms.com/roRomanian
https://www.bms.com/esText duplicate Spanish
https://www.bms.com/seSwedish
https://www.bms.com/chText duplicate German
https://www.bms.com/ch/frText duplicate French
https://www.bms.com/gbText duplicate English
https://www.bms.com/ilHebrew
https://www.bms.com/sa/enText duplicate English
https://www.bms.com/sa/arArabic
https://www.bms.com/trTurkish
https://www.bms.com/ae/enText duplicate English
https://www.bms.com/ae/arText duplicate Arabic
/other-markets.htmlDistributor Markets
/patient-and-caregivers/our-me...Medicines
https://careers.bms.com/jobsExternal Subdomain Text duplicate Careers
https://news.bms.com/External Subdomain Press Releases
https://www.bmsmedinfo.com/External Subdomain Medical Information
/patient-and-caregivers.htmlPatients & caregivers
/patient-and-caregivers/our-me...Text duplicate Our medicines
/patient-and-caregivers/surviv...Survivorship Today
/patient-and-caregivers/patien...Patient resources
/patient-and-caregivers/get-he...Get help paying for your medicines
/patient-and-caregivers/risk-e...Risk evaluation and mitigation strategies (REMS)
/patient-and-caregivers/plain-...Plain language summaries of clinical trial results
/patient-and-caregivers/car-t-...CAR T cell therapy patient resources
/patient-and-caregivers/patien...Immunology patient resources
/about-us/responsibility/posit...Our position on generic drugs
/about-us/responsibility/posit...Our position on drug pricing
/patient-and-caregivers/patien...Psoriasis around the world
/healthcare-providers.htmlHealthcare providers
/healthcare-providers/early-pa...Learn about pre-approval access
/healthcare-providers/post-stu...Learn about post study drug access
/assets/bms/us/en-us/pdf/BMS-3...New window 340B practice fact sheet
http://www.bmsmedinfo.com/External Subdomain U.S. medical information
/researchers-and-partners/clin...Clinical trials
/researchers-and-partners.htmlResearchers
/researchers-and-partners/area...Areas of focus
/researchers-and-partners/in-t...In the pipeline
/researchers-and-partners/our-...R&D expert voices
/researchers-and-partners/prom...Our efforts in STEM
/researchers-and-partners/clin...Clinical trials & research
/researchers-and-partners/inde...Independent research
/researchers-and-partners/bms-...The Thomas O. Daniel research incubator and collaboration center
/researchers-and-partners/pati...Patient safety
/researchers-and-partners/our-...Research publications
/researchers-and-partners/clin...Disclosure commitment
/researchers-and-partners/inde...Areas of interest & research grants
/researchers-and-partners/inde...Data sharing request process
/researchers-and-partners/tran...Translational medicine
/investors.htmlInvestors
/investors/stock-information.htmlStock information
/investors/financial-reporting...Financial reporting
/investors/analyst-coverage.htmlAnalyst coverage
/investors/events-and-presenta...Events and presentations
/investors/shareholder-service...Shareholder services
/investors/celgene-acquisition...Acquisition-related information for Celgene shareholders
/investors/investor-contacts.htmlInvestor contacts
/investors/financial-reporting...New window Annual reports
/investors/stock-information/d...Dividend history
/investors/stock-information/i...Investment return calculator
/investors/financial-reporting...SEC filings
/investors/financial-reporting...Quarterly results
/business-development.htmlBusiness development
/business-development/existing...Our partnerships
/business-development/why-part...Why partner with us
/business-development/science-...Areas of interest
/business-development/partneri...Business development leadership team
/business-development/alliance...Global alliances leadership team
/business-development/early-in...Early innovation at BMS
/business-development/begin-di...Contact Business Development
/assets/bms/us/en-us/pdf/bms-b...New window Download business development brochure
/about-us/our-company/doing-bu...Doing business with us as a supplier
https://www.bms.com/media.htmlNews & media
/media/press-releases.htmlPress releases
/life-and-science.htmlText duplicate Our stories
/media/media-library.htmlMedia library
/media/media-contacts.htmlMedia contacts
/media/media-library/scientifi...Scientific media resources
/media/media-library/disease-s...Disease state resources
/media/media-library/corporate...Corporate resources
https://www.bms.com/about-us.htmlAbout us
/about-us/our-company.htmlOur company
/about-us/leadership.htmlLeadership
/about-us/our-science.htmlText duplicate Our science
/about-us/global-diversity-and...Global Inclusion & Diversity
/about-us/our-impact.htmlOur impact
/about-us/working-at-bms.htmlWorking at BMS
/about-us/contact-us.htmlText duplicate Contact us
/about-us/our-company/global-p...Global Patient Week
/about-us/our-company/our-tech...Our technologies
/about-us/our-company/history-...Our history
/about-us/our-company/worldwid...Our locations
/about-us/responsibility/brist...The Bristol Myers Squibb Foundation
/about-us/global-diversity-and...Resource groups
/about-us/responsibility/posit...Our positions
/life-and-science/science/pred...Science Firsthand Predicting new possibilities in drug discovery
IMG-ALT Digital image of computer numbers and colors
/patient-and-caregivers.htmlPatients & caregivers Discover the resources and information we offer to support you in navigating your healthcare journey.
IMG-ALT Ale & Christophe walking the dog
/about-us/working-at-bms.htmlJoin us in transforming lives At Bristol Myers Squibb, our work helps people prevail over serious diseases, transforming the lives of patients and our employ...
IMG-ALT Woman scientist with sample to light
https://news.bms.com/news/corp...New window External Subdomain 2025 first quarter financial results Read more, including important cautionary statements about forward-looking information.
IMG-ALT Close up of sample with beaker with various colors
/media/media-library/scientifi...Pursuing bold solutions through neuroscience research
IMG-ALT Chris Boerner standing outside a scientific lab
/life-and-science/science/wome...Women innovators in AI transforming patient care
IMG-ALT Female scientist working at dual computer screens with imagery
https://news.bms.com/news/corp...New window External Subdomain New FDA approval Learn about our dual immunotherapy option across all lines of therapy for people with a type of colorectal cancer.
IMG-ALT patient in doctor office with caring hand on shoulder
https://annual-report.bms.com/New window External Subdomain 2024 Annual Report Read more about our progress last year.
IMG-ALT illustrative cover of annual report with BMS branded colors
/media/media-library/scientifi...Scientific media resources Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the developm...
https://news.bms.com/news/corp...New window External Subdomain New FDA approval for the most common type of liver cancer Our dual immunotherapy treatment option is now approved for the first-line treatment of certain pat...
IMG-ALT New FDA approval for the most common type of liver cancer
https://esg.bms.com/New window External Subdomain IMG-ALT mosaic cover of esg report
https://esg.bms.com/New window External Subdomain View our report
/patient-and-caregivers/surviv...Learn more
A-TITLE Learn more
https://careers.bms.com/jobsExternal Subdomain Text duplicate A-TITLE Careers
https://careers.bms.com/jobsExternal Subdomain Text duplicate Learn more
A-TITLE Learn more
/investors.htmlText duplicate A-TITLE Investors
/investors.htmlText duplicate Learn more
A-TITLE Learn more
/researchers-and-partners/clin...Text duplicate Learn more
https://www.bmsstudyconnect.com/External Subdomain Find a clinical trial
http://www.bmsmedinfo.com/External Subdomain Resources for U.S. healthcare providers
http://www.globalbmsmedinfo.com/External Subdomain Global medical information
/patient-and-caregivers/get-he...Find out how
https://www.bms.com/site-map.htmlSitemap
https://www.bms.com/Home
/patient-and-caregivers.htmlText duplicate Patients & caregivers
/healthcare-providers.htmlText duplicate Healthcare providers
/researchers-and-partners.htmlText duplicate Researchers
/investors.htmlText duplicate Investors
https://www.bms.com/media.htmlText duplicate News & media
https://www.bms.com/about-us.htmlText duplicate About us
/patient-and-caregivers/our-me...Text duplicate Our medicines
/legal-notice.htmlLegal notice
/privacy-policy.htmlPrivacy notice center
/trademarks.htmlTrademarks
/forward-looking-statement.htmlNew window Forward-looking statement
/assets/bms/us/english-documen...New window BMS Modern Slavery Statement (PDF)
http://www.facebook.com/Bristo...External Subdomain IMG-ALT Facebook
A-TITLE Facebook
https://www.instagram.com/bris...External Subdomain IMG-ALT Instagram
A-TITLE Instagram
http://twitter.com/BMSNEWSExternal IMG-ALT X
A-TITLE X
http://www.linkedin.com/compan...External Subdomain IMG-ALT LinkedIn
A-TITLE LinkedIn
http://www.youtube.com/bristol...External Subdomain IMG-ALT YouTube
A-TITLE YouTube
https://careers.bms.com/External Subdomain Text duplicate Careers
/life-and-science.htmlText duplicate Our stories
/about-us/contact-us.htmlText duplicate Contact us
/about-us/our-company/worldwid...Worldwide locations

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.bms.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
The web server transmits the web page (HTML) in compressed form.
Performance
(Somewhat important)
The page response time of 0.75 seconds is longer than the recommended limit of 0.4 seconds. A high response time unnecessarily slows down search engine crawling and results in bad user experience as well.
The file size of the HTML document is fine (128 kB).

HTTP Response Header

NameValue
etag"27fc0-635d16eae3208"
last-modifiedFri, 23 May 2025 18:04:41 GMT
content-typetext/html;charset=utf-8
content-length20668
content-encodinggzip
cache-controlmax-age=600, public
age165
dateTue, 27 May 2025 05:18:05 GMT
set-cookie181 Characters
strict-transport-securitymax-age=31536000
x-cdnImperva
x-iinfo2-17045653-17036570 2CNN RT(1748323085519 8) q(0 0 0 0) r(0 0)
statuscode200
http_versionHTTP/2

External factors

This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 4,622 referring domains.
This page has 137,320 backlinks.
This page has backlinks from 3,087 different ip addresses.

Robots.txt

User-agent: *
Disallow: /etc/tags/
Disallow: /apps/
Disallow: /crx/
Disallow: /libs/
Disallow: /bin/
Disallow:  /search-results/jcr:content/searchresults.searchresultsitems.html
Disallow: /content/bmsredesign/
Sitemap: https://www.bms.com/sitemap.xml

Search preview

www.bms.com
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Bristol Myers Squibb75%Check
Global73%Check
company73%Check
Biopharmaceutical73%Check
Global Biopharmaceutical Company73%Check
Patient58%Check
BMS56%Check
medicines55%Check
Patients54%Check
new medicines52%Check

Automatically check bms.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions